Thyroid cancer is the most common endocrine malignancy and its incidence has increased
considerably over the past few decades (1). This Research Topic is devoted to …

Thyroid cancers constitute the most frequent endocrine neoplasia with an incidence of one
to four new cases per 100,000 persons per year, remarkably with 2-to 3-fold higher …

Gene expression profiling (GEP) of normal thyroid tissue from 43 patients with thyroid
carcinoma, 6 with thyroid adenoma, 42 with multinodular goiter, and 6 with Graves-Basedow …

Thyroid cancer is the fastest growing cancer in the US, especially among women. Given the
relative success we have had in its treatment, there is a need to capitalize on it by better …

Poorly differentiated thyroid carcinoma (PDTC) comprises of a well-described entity within
the histopathological parlance of thyroid carcinoma, though its clinical behaviour and …

Molecular signature of advanced and metastatic thyroid carcinoma involves deregulation of
multiple fundamental pathways activated in the tumor microenvironment. They include BRAF …

Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent
advances in biological technologies have been advancing the delineation of genetic …

Cancer is a disorder of the genome. The thyroid cancer genome is being decoded. Recent
studies have identified a mutation or a genetic alteration in 95% of thyroid cancers. The …

Objectives We initiate this comprehensive review to update the advances in this field by
objectively elucidating the efficacies of promising radiopharmaceuticals. Methods We …

Background: While the development of new treatments for aggressive thyroid cancer has
advanced in the last 10 years, progress has trailed headways made with other …